ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TRVI Company Profile and Key Details

NASDAQ : TRVI

Trevi Therapeutics, Inc.

$6.07

-0.03-0.49%

At Close 4:00 PM

58.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Trevi Therapeutics, Inc. (TRVI) stock declined over -0.49%, trading at $6.07 on NASDAQ, down from the previous close of $6.10. The stock opened at $6.08, fluctuating between $5.94 and $6.25 in the recent session.

Stock Snapshot

6.1

Prev. Close

6.08

Open

586.86M

Market Cap

96.68M

Number of Shares

5.94

Day Low

6.25

Day High

-12.91

P/E Ratio

63.93%

Free Float in %

-0.47

EPS (TTM)

0.83

Book Value

-0.32

Cash Flow per Share

650.4K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	6.08	6.39	5.94	6.07	710.02K
Apr 16, 2025	6.20	6.24	5.88	6.10	765.25K
Apr 15, 2025	6.05	6.22	5.88	6.20	845.85K
Apr 14, 2025	5.71	6.00	5.52	5.95	1.18M
Apr 11, 2025	5.26	5.56	5.12	5.56	3.7M
Apr 10, 2025	5.30	5.32	4.85	5.28	1.22M
Apr 09, 2025	5.19	5.58	5.06	5.40	2.87M
Apr 08, 2025	5.95	6.06	5.21	5.30	1.62M
Apr 07, 2025	5.82	6.15	5.43	5.78	1.8M
Apr 04, 2025	5.95	6.11	5.78	6.05	1.47M
Apr 03, 2025	6.04	6.25	5.85	6.22	1.06M
Apr 02, 2025	5.90	6.40	5.78	6.28	1.26M
Apr 01, 2025	6.13	6.23	5.65	6.01	2.73M
Mar 31, 2025	6.25	6.50	6.10	6.29	2.56M
Mar 28, 2025	6.52	6.68	6.36	6.50	944.34K
Mar 27, 2025	6.47	6.56	6.37	6.53	1.18M
Mar 26, 2025	6.58	6.69	6.39	6.47	1.06M
Mar 25, 2025	6.44	6.79	6.37	6.61	1.05M
Mar 24, 2025	6.33	6.52	6.22	6.40	1.17M
Mar 21, 2025	6.52	6.62	6.37	6.47	3.74M

Contact Details

New Haven, CT 06510

United States

Website: https://www.trevitherapeutics.comContact: 203 304 2499

About Company

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Frequently Asked Questions

What is the current Trevi Therapeutics, Inc. (TRVI) stock price?

Trevi Therapeutics, Inc. (NASDAQ: TRVI) stock price is $6.07 in the last trading session. During the trading session, TRVI stock reached the peak price of $6.25 while $5.94 was the lowest point it dropped to. The percentage change in TRVI stock occurred in the recent session was -0.49% while the dollar amount for the price change in TRVI stock was -$0.03.

TRVI's industry and sector of operation?

The NASDAQ listed TRVI is part of Biotechnology industry that operates in the broader Healthcare sector. Trevi Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TRVI?

Mr. Christopher Galletta
Controller & Chief Accounting Officer
Ms. Jennifer L. Good
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Thomas R. Sciascia M.D.
Co-Founder & Chief Science Officer
Ms. Danine Summers
Vice President of Medical Affairs
Katie McManus
Communications Mang.
Mr. Farrell Simon Pharm.D.
Chief Commercial Officer
Dr. David J. Clark A.F.P.M., M.D., M.R.C.P.
Chief Medical Officer
Ms. Lisa Delfini
Chief Financial Officer

How TRVI did perform over past 52-week?

TRVI's closing price is 163.91% higher than its 52-week low of $2.30 where as its distance from 52-week high of $7.39 is -17.86%.

How many employees does TRVI have?

Number of TRVI employees currently stands at 26.

Link for TRVI official website?

Official Website of TRVI is: https://www.trevitherapeutics.com

How do I contact TRVI?

TRVI could be contacted at phone 203 304 2499 and can also be accessed through its website. TRVI operates from 195 Church Street, New Haven, CT 06510, United States.

How many shares of TRVI are traded daily?

TRVI stock volume for the day was 650.4K shares. The average number of TRVI shares traded daily for last 3 months was 2.15M.

What is the market cap of TRVI currently?

The market value of TRVI currently stands at $586.86M with its latest stock price at $6.07 and 96.68M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	26
Beta	0.41
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology